SGLT2i: Therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

Jiajia Wu, Hong Cai, Jia Xia, Tianyi Zhang, Jiayi Yan, Xinhua Shao, Amanda Ying Wang, Jianxiao Shen, Shan Mou

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number106883
JournalPharmacological Research
StatePublished - Sep 2023
Externally publishedYes


  • Contrast induced acute kidney injury (CI-AKI)
  • Non-diabetes
  • Predisposing factors
  • Sodium-glucose cotransporter 2 inhibitors (SGLT2i)
  • Treatment measures

Cite this